Pain Therapeutics Company Profile (NASDAQ:PTIE)

About Pain Therapeutics

Pain Therapeutics logoPain Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on drug development efforts on disorders of the nervous system, such as chronic pain. The Company's lead drug candidate, REMOXY, is an abuse-deterrent, oral formulation of oxycodone (CII). The Company's other products is FENROCK. REMOXY is a painkiller with a formulation designed to reduce potential risks of unintended use. The Company has developed REMOXY to make oxycodone difficult to abuse yet provide approximately 12 hours of steady pain relief when used by patients. REMOXY is intended to meet the needs of healthcare prescribing opioid drugs and seeking to minimize the risks of drug diversion, abuse or accidental patient misuse. The Company's drug candidate FENROCK is an abuse-deterrent transdermal pain patch in the pre-Investigational new drug-stage of development. FENROCK is designed to provide pain relief over 72 hours.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: PTIE
  • CUSIP: 69562K10
Key Metrics:
  • Previous Close: $0.59
  • 50 Day Moving Average: $0.5871
  • 200 Day Moving Average: $1.1676
  • 52-Week Range: $0.51 - $3.00
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.37
  • P/E Growth: -0.0200
  • Market Cap: $27.00M
  • Outstanding Shares: 45,742,000
  • Beta: 2.13
Profitability:
  • Return on Equity: -68.80%
  • Return on Assets: -62.42%
Debt:
  • Current Ratio: 10.29%
  • Quick Ratio: 10.29%
Additional Links:
Companies Related to Pain Therapeutics:

Analyst Ratings

Consensus Ratings for Pain Therapeutics (NASDAQ:PTIE) (?)
Ratings Breakdown: 1 Hold Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $2.50 (323.59% upside)

Analysts' Ratings History for Pain Therapeutics (NASDAQ:PTIE)
Show:
DateFirmActionRatingPrice TargetDetails
9/13/2016GabelliDowngradeBuy -> Hold$2.50View Rating Details
(Data available from 2/22/2015 forward)

Earnings

Earnings History for Pain Therapeutics (NASDAQ:PTIE)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/27/2017        
10/20/2016Q316($0.09)($0.08)ViewN/AView Earnings Details
7/19/2016Q216($0.14)($0.07)ViewN/AView Earnings Details
5/5/2016Q1($0.10)($0.13)ViewN/AView Earnings Details
10/30/2014Q314($0.08)$89.70 millionViewN/AView Earnings Details
8/5/2014Q214($0.07)ViewN/AView Earnings Details
5/6/2014Q1 14($0.06)($0.08)$1.96 millionViewN/AView Earnings Details
2/4/2014Q413($0.01)$0.72$2.00 million$35.24 millionViewN/AView Earnings Details
10/31/2013Q313($0.01)($0.02)$2.00 million$1.96 millionViewN/AView Earnings Details
4/24/2013Q1 2013($0.01)($0.01)$2.80 million$1.96 millionViewN/AView Earnings Details
2/6/2013Q4 2012($0.02)($0.08)$2.79 million$2.47 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Pain Therapeutics (NASDAQ:PTIE)
Current Year EPS Consensus Estimate: $-0.4300 EPS
Next Year EPS Consensus Estimate: $-0.4300 EPS

Dividends

Dividend History for Pain Therapeutics (NASDAQ:PTIE)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
12/11/2012special$0.7512/13/201212/17/201212/24/2012
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Pain Therapeutics (NASDAQ:PTIE)
Insider Ownership Percentage: 32.40%
Institutional Ownership Percentage: 44.34%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/6/2013Sanford RobertsonDirectorBuy50,000$3.73$186,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Pain Therapeutics (NASDAQ:PTIE)
DateHeadline
News IconHere’s What The Latest Pain Therapeutics, Inc. (PTIE) Update Means (NASDAQ:PTIE)
feedproxy.google.com - February 21 at 11:51 AM
News IconPain Therapeutics, Inc. (PTIE) held by 12 SEC 13F Filers - Post Analyst (NASDAQ:PTIE)
postanalyst.com - February 20 at 6:37 PM
marketexclusive.com logoPain Therapeutics, Inc. (NASDAQ:PTIE) Files An 8-K Results of Operations and Financial Condition (NASDAQ:PTIE)
marketexclusive.com - February 20 at 9:19 AM
News IconRatings & Stock Target Updates on Pain Therapeutics, Inc. (NASDAQ:PTIE) Two River Bancorp (NASDAQ:TRCB) - Rockville Register (NASDAQ:PTIE)
rockvilleregister.com - February 19 at 9:18 AM
4-traders.com logoPain Therapeutics : reports 4Q loss (NASDAQ:PTIE)
www.4-traders.com - February 18 at 6:29 PM
seekingalpha.com logoPain Therapeutics finance chief bids adieu (NASDAQ:PTIE)
seekingalpha.com - February 18 at 6:29 PM
us.rd.yahoo.com logoPain Therapeutics Reports 2016 Financial Results (NASDAQ:PTIE)
us.rd.yahoo.com - February 18 at 6:29 PM
biz.yahoo.com logoPAIN THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:PTIE)
us.rd.yahoo.com - February 18 at 6:29 PM
us.rd.yahoo.com logo9:09 am Pain Therapeutics discloses that it and the FDA reached an agreement on a roadmap to resubmit the New Drug Application for REMOXY ER (NASDAQ:PTIE)
us.rd.yahoo.com - February 18 at 6:29 PM
News IconBuy, Sell or Hold Seanergy Maritime Holdings Corp. (NASDAQ:SHIP) Pain Therapeutics, Inc. (NASDAQ:PTIE ... - Rives Journal (NASDAQ:PTIE)
rivesjournal.com - February 17 at 8:05 PM
globenewswire.com logoPain Therapeutics Reports 2016 Financial Results - GlobeNewswire (press release) (NASDAQ:PTIE)
globenewswire.com - February 17 at 8:05 PM
sg.finance.yahoo.com logoPain Therapeutics reports 4Q loss (NASDAQ:PTIE)
sg.finance.yahoo.com - February 17 at 8:05 PM
seekingalpha.com logoPain Therapeutics net loss improves in Q4 (NASDAQ:PTIE)
seekingalpha.com - February 17 at 10:01 AM
News IconMA Watch on Shares of Pain Therapeutics Inc. (PTIE) - Rives Journal (NASDAQ:PTIE)
rivesjournal.com - February 15 at 5:00 AM
News IconCritical Profitability Ratio Analysis: Amgen Inc. (NASDAQ:AMGN), Pain Therapeutics, Inc. (NASDAQ:PTIE) - Street Wise Report (press release) (blog) (NASDAQ:PTIE)
streetwisereport.com - February 10 at 3:10 AM
News IconTrading Scope: ADX and CCI Review for Pain Therapeutics Inc. (PTIE) - Sherwood Daily (NASDAQ:PTIE)
sherwooddaily.com - February 1 at 10:08 PM
News IconStock Picks With Profit Margins Analysis: Cara Therapeutics (NASDAQ:CARA), Pain Therapeutics (NASDAQ:PTIE) - Street Wise Report (press release) (blog) (NASDAQ:PTIE)
streetwisereport.com - February 1 at 10:07 PM
News IconUnusual Volume Sighted in Shares of Pain Therapeutics, Inc. (NASDAQ:PTIE) - Aiken Advocate (NASDAQ:PTIE)
aikenadvocate.com - February 1 at 10:07 PM
News IconInvestor Corner: Checking the Charts for Pain Therapeutics Inc. (PTIE) - Sherwood Daily (NASDAQ:PTIE)
sherwooddaily.com - January 31 at 1:04 AM
News IconOff To a Slow Start in The New Year, Stock Looks For a Turnaround: Pain Therapeutics, Inc. (NASDAQ:PTIE) - Aiken Advocate (NASDAQ:PTIE)
aikenadvocate.com - January 29 at 8:39 AM
fool.com logoPain Therapeutics PTIE (NASDAQ:PTIE)
www.fool.com - January 29 at 12:31 AM
News IconAverage Directional Index Review for Pain Therapeutics Inc. (PTIE) - Sherwood Daily (NASDAQ:PTIE)
sherwooddaily.com - January 28 at 5:50 AM
News IconRSI Review on Shares of Pain Therapeutics Inc. (PTIE) - Sherwood Daily (NASDAQ:PTIE)
sherwooddaily.com - January 26 at 2:21 AM
News IconTrading Sheet: Tracking Technicals for Pain Therapeutics Inc. (PTIE) - Sherwood Daily (NASDAQ:PTIE)
sherwooddaily.com - January 25 at 1:12 AM
News IconIs There Any Upside to This Stock Under $5: Pain Therapeutics, Inc ... - Prospect Journal (NASDAQ:PTIE)
prospectjournal.com - January 24 at 12:41 AM
News IconWhich Direction is This Stock Headed? Update on Pain Therapeutics, Inc. (NASDAQ:PTIE) - Prospect Journal (NASDAQ:PTIE)
prospectjournal.com - January 19 at 12:58 AM
News IconTracking CCI Levels on Shares of Pain Therapeutics Inc. (PTIE) - Sherwood Daily (NASDAQ:PTIE)
sherwooddaily.com - January 18 at 12:45 AM
News IconBargain Hunters Should Take a Look at Pain Therapeutics, Inc. (NASDAQ:PTIE) - Prospect Journal (NASDAQ:PTIE)
prospectjournal.com - January 18 at 12:45 AM
News IconPlacing This Stock in the Hotbed: Pain Therapeutics, Inc. (NASDAQ:PTIE) - Prospect Journal (NASDAQ:PTIE)
prospectjournal.com - January 18 at 12:45 AM
News IconNASDAQ:PTIE Investor News: Deadline upcoming in Settlement of the Lawsuit against Pain Therapeutics Inc (NASDAQ:PTIE)
www.groundreport.com - January 16 at 7:50 PM
News IconPrimed for Breakout or Bust? A look at Pain Therapeutics, Inc. (NASDAQ:PTIE) - Prospect Journal (NASDAQ:PTIE)
prospectjournal.com - January 11 at 1:38 AM
News IconPlacing the Bulls-Eye Focus on Pain Therapeutics, Inc. (NASDAQ:PTIE) - Prospect Journal (NASDAQ:PTIE)
prospectjournal.com - January 11 at 1:38 AM
sbwire.com logoDeadline Upcoming in $8.5 Million Settlement in the Pain Therapeutics Inc (NASDAQ: PTIE) Investor Lawsuit (NASDAQ:PTIE)
www.sbwire.com - January 10 at 8:37 PM
News IconShould Farsighted Investors Pay Attention to Pain Therapeutics, Inc. (NASDAQ:PTIE) - Prospect Journal (NASDAQ:PTIE)
prospectjournal.com - January 5 at 8:28 PM
News IconNear-Term, Can This Stock Move the Needle: Pain Therapeutics, Inc. (NASDAQ:PTIE) - Prospect Journal (NASDAQ:PTIE)
prospectjournal.com - January 4 at 3:18 PM
News IconIs the Needle Ready to Move on Pain Therapeutics, Inc. (NASDAQ:PTIE) - Prospect Journal (NASDAQ:PTIE)
prospectjournal.com - January 4 at 12:06 AM
News IconValue Score Review for Pain Therapeutics, Inc. (NASDAQ:PTIE) - Wall Street Beacon (NASDAQ:PTIE)
wsbeacon.com - January 4 at 12:06 AM
News IconAre There Any Catalysts to Propel This Stock Forward: Pain Therapeutics, Inc. (NASDAQ:PTIE) - Prospect Journal (NASDAQ:PTIE)
prospectjournal.com - December 23 at 7:49 AM
News IconAre There Any Catalysts to Propel This Stock Forward: Pain ... - Prospect Journal (NASDAQ:PTIE)
prospectjournal.com - December 22 at 7:42 PM
4-traders.com logoPain Therapeutics : to Discuss REMOXY ER with FDA (NASDAQ:PTIE)
www.4-traders.com - December 22 at 1:14 AM
News IconCan This Stock Pick Up Any Momentum: Pain Therapeutics, Inc. (NASDAQ:PTIE) - Prospect Journal (NASDAQ:PTIE)
prospectjournal.com - December 21 at 8:12 PM
News IconEquity Review: Looking Closer at Shares of Pain Therapeutics, Inc. (NASDAQ:PTIE) - Liberty News (NASDAQ:PTIE)
libertynewsrecord.com - December 21 at 8:12 PM
News IconCan This Stock Grab Upward Traction: Pain Therapeutics, Inc. (NASDAQ:PTIE) - Prospect Journal (NASDAQ:PTIE)
prospectjournal.com - December 21 at 9:18 AM
News IconCompany Focus on Pain Therapeutics, Inc. (NASDAQ:PTIE) - Liberty News (NASDAQ:PTIE)
libertynewsrecord.com - December 20 at 1:59 PM
News IconCompany Stock in Focus: Pain Therapeutics, Inc. (NASDAQ:PTIE) - OIB News (NASDAQ:PTIE)
oibnews.com - December 20 at 1:59 PM
globenewswire.com logoPain Therapeutics to Discuss REMOXY® ER with FDA - GlobeNewswire (press release) (NASDAQ:PTIE)
globenewswire.com - December 20 at 1:59 PM
finance.yahoo.com logo9:02 am Pain Therapeutics to meet w/ the FDA on February 13, 2017 to discuss the regulatory path forward for REMOXY ER (NASDAQ:PTIE)
finance.yahoo.com - December 20 at 1:59 PM
publicnow.com logoPain Therapeutics to Discuss REMOXY® ER with FDA (NASDAQ:PTIE)
www.publicnow.com - December 20 at 1:59 PM
prnewswire.com logoResearch Reports Initiation on Biotech Stocks -- Pacific Biosciences of California, Aralez Pharma, Cerus, and Pain ... - PR Newswire (press release) (NASDAQ:PTIE)
www.prnewswire.com - December 19 at 8:29 AM
News IconInvestor List: Watching Shares of Pain Therapeutics, Inc. (NASDAQ:PTIE) - Business Daily Leader (NASDAQ:PTIE)
businessdailyleader.com - December 19 at 8:29 AM

Social

What is Pain Therapeutics' stock symbol?

Pain Therapeutics trades on the NASDAQ under the ticker symbol "PTIE."

Where is Pain Therapeutics' stock going? Where will Pain Therapeutics' stock price be in 2017?

1 equities research analysts have issued twelve-month target prices for Pain Therapeutics' stock. Their forecasts range from $2.50 to $2.50. On average, they anticipate Pain Therapeutics' share price to reach $2.50 in the next year.

When will Pain Therapeutics announce their earnings?

Pain Therapeutics is scheduled to release their next quarterly earnings announcement on Monday, February, 27th 2017.

Who owns Pain Therapeutics stock?

Pain Therapeutics' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (1.81%) and Gabelli Funds LLC (0.38%).

Who sold Pain Therapeutics stock? Who is selling Pain Therapeutics stock?

Pain Therapeutics' stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC.

Who bought Pain Therapeutics stock? Who is buying Pain Therapeutics stock?

Pain Therapeutics' stock was acquired by a variety of institutional investors in the last quarter, including Gabelli Funds LLC.

How do I buy Pain Therapeutics stock?

Shares of Pain Therapeutics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Pain Therapeutics stock cost?

One share of Pain Therapeutics stock can currently be purchased for approximately $0.59.

Pain Therapeutics (NASDAQ:PTIE) Chart for Wednesday, February, 22, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Pain Therapeutics (NASDAQ:PTIE)

Earnings History Chart

Earnings by Quarter for Pain Therapeutics (NASDAQ:PTIE)

Dividend History Chart

Dividend Payments by Quarter for Pain Therapeutics (NASDAQ:PTIE)

Last Updated on 2/22/2017 by MarketBeat.com Staff